Overlapping conditions in Long COVID at a multisite academic center
- PMID: 39524912
- PMCID: PMC11543549
- DOI: 10.3389/fneur.2024.1482917
Overlapping conditions in Long COVID at a multisite academic center
Abstract
Background: Many patients experience persistent symptoms after COVID-19, a syndrome referred to as Long COVID (LC). The goal of this study was to identify novel new or worsening comorbidities self-reported in patients with LC.
Methods: Patients diagnosed with LC (n = 732) at the Mayo Long COVID Care Clinic in Rochester, Minnesota and Jacksonville, Florida were sent questionnaires to assess the development of new or worsening comorbidities following COVID-19 compared to patients with SARS-CoV-2 that did not develop LC (controls). Both groups were also asked questions screening for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), generalized joint hypermobility (GJH) and orthostatic intolerance. 247 people with LC (33.7%) and 40 controls (50%) responded to the surveys.
Results: In this study LC patients averaged 53 years of age and were predominantly White (95%) women (75%). The greatest prevalence of new or worsening comorbidities following SARS-CoV-2 infection in patients with LC vs. controls reported in this study were pain (94.4% vs. 0%, p < 0.001), neurological (92.4% vs. 15.4%, p < 0.001), sleep (82.8% vs. 5.3%, p < 0.001), skin (69.8% vs. 0%, p < 0.001), and genitourinary (60.6% vs. 25.0%, p = 0.029) issues. 58% of LC patients screened positive for ME/CFS vs. 0% of controls (p < 0.001), 27% positive for GJH compared to 10% of controls (p = 0.026), and a positive average score of 4.0 on orthostatic intolerance vs. 0 (p < 0.001). The majority of LC patients with ME/CFS were women (77%).
Conclusion: We found that comorbidities across 12 surveyed categories were increased in patients following SARS-CoV-2 infection. Our data also support the overlap of LC with ME/CFS, GJH, and orthostatic intolerance. We discuss the pathophysiologic, research, and clinical implications of identifying these conditions with LC.
Keywords: SARS-CoV-2; generalized joint hypermobility; hypermobile Ehlers-Danlos syndrome; mast cells; myalgic encephalomyelitis/chronic fatigue syndrome; orthostatic intolerance; pain; virus.
Copyright © 2024 Grach, Dudenkov, Pollack, Fairweather, Aakre, Munipalli, Croghan, Mueller, Overgaard, Bruno, Collins, Li, Hurt, Tal, Ganesh and Knight.
Conflict of interest statement
RTH is a consultant for Nestle Nutrition. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Similar articles
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Comparing DNA Methylation Landscapes in Peripheral Blood from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID Patients.Int J Mol Sci. 2025 Jul 10;26(14):6631. doi: 10.3390/ijms26146631. Int J Mol Sci. 2025. PMID: 40724879 Free PMC article.
-
AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.Clin Gastroenterol Hepatol. 2025 Jul;23(8):1291-1302. doi: 10.1016/j.cgh.2025.02.015. Epub 2025 May 19. Clin Gastroenterol Hepatol. 2025. PMID: 40387691 Review.
-
Elevated risk of new-onset chronic fatigue syndrome/myalgic encephalomyelitis up to four years after SARS-CoV-2 infection.J Transl Med. 2025 Jul 23;23(1):815. doi: 10.1186/s12967-025-06625-w. J Transl Med. 2025. PMID: 40702518 Free PMC article.
-
Exercise therapy for chronic fatigue syndrome.Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD003200. doi: 10.1002/14651858.CD003200.pub9. Cochrane Database Syst Rev. 2024. PMID: 39697147
References
-
- Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, et al. . Long COVID in adults discharged from UK hospitals after COVID-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg Health Eur. (2021) 8:100186. doi: 10.1016/j.lanepe.2021.100186, PMID: - DOI - PMC - PubMed
-
- (ASPA) ASfPA . Terms & definitions. COVID.gov (2023). Available at: https://www.covid.gov/be-informed/longcovid/about (Accessed August 18, 2024).
-
- National Academies of Sciences E, Medicine In: Fineberg HV, Brown L, Worku T, Goldowitz I, editors. A long COVID definition: a chronic, systemic disease state with profound consequences. Washington, DC: The National Academies Press; (2024). 186. - PubMed
-
- Bureau NCfHSUSC . Household pulse survey, 2022–2024. Long COVID. Available at: https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm (Accessed August 18, 2024).
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous